The pattern no single source sees

Search

Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.

Company or person15

RenovoRx, Inc.

Company

5 records in the corpus

RENN Fund, Inc.

Company

1 records in the corpus

RESMED INC

Company

8 records in the corpus

REED'S, INC.

Company

5 records in the corpus

Reddit, Inc.

Company

13 records in the corpus

Rezera Inc.

Company

2 records in the corpus

REVVITY, INC.

Company

7 records in the corpus

RPC INC

Company

10 records in the corpus

NOV Inc.

Company

1 records in the corpus

RXO, Inc.

Company

6 records in the corpus

NNN REIT, INC.

Company

11 records in the corpus

CERENOME, INC.

Company

11 records in the corpus

Rezolute, Inc.

Company

9 records in the corpus

REALLOYS INC.

Company

1 records in the corpus

RELIANCE, INC.

Company

2 records in the corpus

Primary record6

BOSTON SCIENTIFIC CORP filed SCHEDULE 13G/A

0001104659-26-123910.txt : 20261106 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0000885725 XXXXXXXX LIVE 1 Common Stock 09/30/2026 0001574094 RenovoRx, Inc. 75989R107 2570 West El Camino Real Suite 640 Mountain

06 Nov 2026 · sec daily index

RenovoRx, Inc. filed 8-K

Item 2.02 Results of Operations and Financial Condition. On November 5, 2026, RenovoRx, Inc. issued a press release announcing its financial results as of and for the quarter ended September 30, 2026. The full text of th

05 Nov 2026 · sec daily index

RenovoRx, Inc. filed 4

SEC form 4 filed by RenovoRx, Inc. (CIK 1574094) on 2026-10-02.

02 Oct 2026 · sec daily index

RenovoRx, Inc. filed 4

SEC form 4 filed by RenovoRx, Inc. (CIK 1574094) on 2026-09-15.

15 Sep 2026 · sec daily index

RenovoRx, Inc. filed 8-K

Item 8.01 Other Events. RenovoRx Regains Compliance with Nasdaq Minimum Bid Price Requirement As previously disclosed, on December 31, 2025, RenovoRx, Inc. (the “Company”) received a written notice from the Listing Quali

20 Aug 2026 · sec daily index

RenovoRx, Inc. filed 8-K

Item 2.02 Results of Operations and Financial Condition. On August 12, 2026, RenovoRx, Inc. issued a press release announcing its financial results as of and for the quarter ended June 30, 2026. The full text of the pres

12 Aug 2026 · sec daily index